1.56
-0.04(-2.50%)
Currency In USD
| Previous Close | 1.6 |
| Open | 1.6 |
| Day High | 1.69 |
| Day Low | 1.56 |
| 52-Week High | 1.95 |
| 52-Week Low | 0.76 |
| Volume | 41,585 |
| Average Volume | 187,193 |
| Market Cap | 58.96M |
| PE | -2.89 |
| EPS | -0.54 |
| Moving Average 50 Days | 1.21 |
| Moving Average 200 Days | 1.32 |
| Change | -0.04 |
If you invested $1000 in Apyx Medical Corporation (APYX) since IPO date, it would be worth $241.11 as of June 01, 2025 at a share price of $1.56. Whereas If you bought $1000 worth of Apyx Medical Corporation (APYX) shares 5 years ago, it would be worth $383.29 as of June 01, 2025 at a share price of $1.56.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Apyx Medical Corporation Receives FDA Clearance for the AYON Body Contouring System™
GlobeNewswire Inc.
May 13, 2025 12:00 PM GMT
The AYON Body Contouring System is the first FDA cleared all-in-one platform for the aesthetic surgical suite Plan to initiate the commercial launch of the AYON Body Contouring System to key opinion leader surgeons in critical geographies during the
Apyx Medical Corporation Announces Two Peer-Reviewed Publications on the Use of Renuvion in Abdominal Body Contouring Procedures
GlobeNewswire Inc.
Apr 29, 2025 12:00 PM GMT
Two studies report favorable clinical outcomes and safety data for Renuvion® when used during procedures that include lipoabdominoplasty for the treatment of loose and lax skin Rapid weight loss due to GLP-1 drugs expected to drive growth in patients
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025
GlobeNewswire Inc.
Apr 24, 2025 12:45 PM GMT
CLEARWATER, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announ